Thermo Fisher Scientific launched its Oncomine TCR Beta-SR Assay, a new next-generation sequencing (NGS) solution for immuno-oncology research designed to characterize T-cell clonality in the tumor microenvironment in order to identify potential biomarkers associated with immune response.   Leveraging T-cell receptor diversity through a targeted sequencing approach is believed to provide the highest level of resolution to help identify predictive and prognostic biomarkers associated with cance...